G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.In VitroG3-C12 is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but shows no affinity for other galectin family members or to other lectins.
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but
G3-C12 (TFA) is a galectin-3 binding peptide, with K d of 88 nM, and shows anticancer activity.Appearance:SolidIC50& Target:Kd: 88 nM (Galectin-3) .In Vitro:G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (K d ) of 88 nM, but